NO LONGER ACTIVE
Send Opposition Comments on Federal OSHA Rule for Employer Covid Vaccine, Masking, and Testing
Tell OSHA the Emergency Rule should NOT be adopted as a final standard!
OSHA is requesting public comments for the next 30 days as to whether the Emergency Temporary Standard (ETS) agency rule for employer COVID vaccine, masking, and testing requirements, should become a final standard. Although the ETS, aka Biden’s Mandate, is to take effect immediately on November 5, 2021, OSHA states that it also serves as a proposal under statute for a final standard. We do not want this to become a final standard!
In addition, OSHA is requesting comments on the rule’s entire content including such things as whether to apply the standard in the future to small businesses; “OSHA encourages commenters to explain why they prefer or disfavor particular policy choices, and include any relevant studies, experiences, anecdotes or other information that may help support the comment.”
Reasons to Oppose the ETS:
Personal health care decisions should not be dictated by employment requirements.
It is the result of Federal overreach by the Biden Administration using an agency to accomplish what cannot legally be done by a President.
As discussed by the plaintiffs in BST Holdings, et al. v. OSHA, it exceeds OSHA’s authority under its enabling statute; it exceeds Congress’s authority under the Commerce Clause; and it exceeds Congress’s authority under the nondelegation doctrine.
For background on the ETS, read NHFA’s post opposing President Biden’s Mandate here. OSHA was tasked with implementing the mandate.
Please submit comments despite the stay of enforcement of the ETS (the “Mandate”) as ordered by the 5th Circuit in BST Holdings, et al. v. OSHA, on Saturday, November 6. As the order makes clear, the stay of enforcement is only valid “pending further action by the court.”
The ETS temporary rule has been published in the Federal Register and is a lengthy 490 page document including a detailed preamble as to the rationale and legal authority in proposing the ETS. You can read the entire Federal Register document HERE. However, the following is the actual proposed rule that you can also find at the end of the Federal Register publication:
*************************************************************
For the reasons set forth in the preamble, chapter XVII of title 29 of the Code of Federal Regulations is amended as follows:
PART 1910—OCCUPATIONAL SAFETY AND HEALTH STANDARDS
Subpart U — COVID-19
1. Revise the heading for Subpart U to read as set forth above.
2. The authority citation for subpart U continues to read as follows:
Authority: 29 U.S.C. 653, 655, and 657; Secretary of Labor’s Order No. 8-2020 (85 FR 58393); 29 CFR part 1911; and 5 U.S.C. 553.
3. Add § 1910.501 to subpart U to read as follows:
§ 1910.501 Vaccination, testing, and face coverings.
(a) Purpose. This section is intended to establish minimum vaccination, vaccination
verification, face covering, and testing requirements to address the grave danger of
COVID-19 in the workplace, and to preempt inconsistent state and local requirements
relating to these issues, including requirements that ban or limit employers’ authority to
require vaccination, face covering, or testing, regardless of the number of employees.
Note 1 to paragraph (a): This section establishes minimum requirements that employers
must implement. Nothing in this section prevents employers from agreeing with workers
and their representatives to additional measures not required by this section and this
section does not supplant collective bargaining agreements or other collectively
negotiated agreements in effect that may have negotiated terms that exceed the
requirements herein. The National Labor Relations Act of 1935 (NLRA) protects
the right of most private-sector employees to take collective action to improve their
wages and working conditions.
(b) Scope and application.
(1) This section covers all employers with a total of 100 or
more employees at any time this section is in effect.
(2) The requirements of this section do not apply to:
(i) Workplaces covered under the Safer Federal Workforce Task Force COVID19 Workplace Safety: Guidance for Federal Contractors and Subcontractors;
or
(ii) Settings where any employee provides healthcare services or healthcare
support services when subject to the requirements of § 1910.502.
(3) The requirements of this section do not apply to the employees of covered
employers:
(i) Who do not report to a workplace where other individuals such as coworkers
or customers are present;
(ii) While working from home; or
(iii) Who work exclusively outdoors.
(c) Definitions. The following definitions apply to this section.
Assistant Secretary means the Assistant Secretary of Labor for Occupational Safety
and Health, U.S. Department of Labor, or designee.
COVID-19 (Coronavirus Disease 2019) means the disease caused by SARS-CoV-2
(severe acute respiratory syndrome coronavirus 2). For clarity and ease of reference, this
section also uses the term “COVID-19” when describing exposures or potential
exposures to SARS-CoV-2.
COVID-19 test means a test for SARS-CoV-2 that is:
(i) Cleared, approved, or authorized, including in an Emergency Use
Authorization (EUA), by the FDA to detect current infection with the SARSCoV-2 virus (e.g., a viral test);
(ii) Administered in accordance with the authorized instructions; and
(iii) Not both self-administered and self-read unless observed by the employer or
an authorized telehealth proctor. Examples of tests that satisfy this
requirement include tests with specimens that are processed by a laboratory
(including home or on-site collected specimens which are processed either
individually or as pooled specimens), proctored over-the-counter tests, point
of care tests, and tests where specimen collection and processing is either
done or observed by an employer.
Face covering means a covering that:
(i)
(A) completely covers the nose and mouth;
(B) Is made with two or more layers of a breathable fabric that is tightly
woven (i.e., fabrics that do not let light pass through when held up to a
light source);
(C) Is secured to the head with ties, ear loops, or elastic bands that go behind
the head. If gaiters are worn, they should have two layers of fabric or be
folded to make two layers;
(D) Fits snugly over the nose, mouth, and chin with no large gaps on the
outside of the face; and
(E) Is a solid piece of material without slits, exhalation valves, visible holes,
punctures, or other openings.
(ii) This definition includes clear face coverings or cloth face coverings with a
clear plastic panel that, despite the non-cloth material allowing light to pass
through, otherwise meet this definition and which may be used to facilitate
communication with people who are deaf or hard-of-hearing or others who
need to see a speaker’s mouth or facial expressions to understand speech or
sign language respectively.
Facemask means a surgical, medical procedure, dental, or isolation mask that is FDAcleared, authorized by an FDA EUA, or offered or distributed as described in an FDA enforcement policy. Facemasks may also be referred to as ‘‘medical procedure masks.’’
Fully vaccinated means:
(i) A person’s status 2 weeks after completing primary vaccination with a
COVID-19 vaccine with, if applicable, at least the minimum recommended
interval between doses in accordance with the approval, authorization, or
listing that is:
(A) Approved or authorized for emergency use by the FDA;
(B) Listed for emergency use by the World Health Organization (WHO); or
(C) Administered as part of a clinical trial at a U.S. site, if the recipient is
documented to have primary vaccination with the active (not placebo)
COVID-19 vaccine candidate, for which vaccine efficacy has been
independently confirmed (e.g., by a data and safety monitoring board) or if
the clinical trial participant at U.S. sites had received a COVID-19 vaccine
that is neither approved nor authorized for use by FDA but is listed for
emergency use by WHO; or
(ii) A person’s status 2 weeks after receiving the second dose of any combination
of two doses of a COVID-19 vaccine that is approved or authorized by the
FDA, or listed as a two-dose series by the WHO (i.e., a heterologous primary
series of such vaccines, receiving doses of different COVID-19 vaccines as
part of one primary series). The second dose of the series must not be received
earlier than 17 days (21 days with a 4-day grace period) after the first dose.
Mandatory Vaccination Policy is an employer policy requiring each employee to be
fully vaccinated. To meet this definition, the policy must require: vaccination of all
employees, including vaccination of all new employees as soon as practicable, other than
those employees:
(i) For whom a vaccine is medically contraindicated;
(ii) For whom medical necessity requires a delay in vaccination; or
(iii) Who are legally entitled to a reasonable accommodation under federal civil
rights laws because they have a disability or sincerely held religious beliefs,
practices, or observances that conflict with the vaccination requirement.
Respirator means a type of personal protective equipment (PPE) that is certified by
the National Institute for Occupational Safety and Health (NIOSH) under 42 CFR part 84
or is authorized under an EUA by the FDA. Respirators protect against airborne hazards
by removing specific air contaminants from the ambient (surrounding) air or by
supplying breathable air from a safe source. Common types of respirators include
filtering facepiece respirators (e.g., N95), elastomeric respirators, and powered air
purifying respirators (PAPRs). Face coverings, facemasks, and face shields are not
respirators.
Workplace means a physical location (e.g., fixed, mobile) where the employer’s work
or operations are performed. It does not include an employee’s residence.
(d) Employer policy on vaccination.
(1) The employer must establish, implement, and
enforce a written mandatory vaccination policy.
(2) The employer is exempted from the requirement in paragraph (d)(1) of this
section only if the employer establishes, implements, and enforces a written
policy allowing any employee not subject to a mandatory vaccination policy to
choose either to be fully vaccinated against COVID-19 or provide proof of regular
testing for COVID-19 in accordance with paragraph (g) of this section and wear a
face covering in accordance with paragraph (i) of this section.
Note 1 to paragraph (d): Under federal law, including the Americans with Disabilities
Act (ADA) and Title VII of the Civil Rights Act of 1964, workers may be entitled to a
reasonable accommodation from their employer, absent undue hardship. If the worker
requesting a reasonable accommodation cannot be vaccinated and/or wear a face
covering because of a disability, as defined by the ADA, the worker may be entitled to a
reasonable accommodation. In addition, if the vaccination, and/or testing for COVID-19,
and/or wearing a face covering conflicts with a worker’s sincerely held religious belief,
practice or observance, the worker may be entitled to a reasonable accommodation. For
more information about evaluating requests for reasonable accommodation for disability
or sincerely held religious belief, employers should consult the Equal Employment
Opportunity Commission’s regulations, guidance, and technical assistance including at:
https://www.eeoc.gov/wysk/what-you-should-know-about-covid-19-and-adarehabilitation-act-and-other-eeo-laws.
(e) Determination of employee vaccination status.
(1) The employer must determine the
vaccination status of each employee. This determination must include whether the
employee is fully vaccinated.
(2) The employer must require each vaccinated employee to provide acceptable proof
of vaccination status, including whether they are fully or partially vaccinated.
Acceptable proof of vaccination status is:
(i) The record of immunization from a health care provider or pharmacy;
(ii) A copy of the COVID-19 Vaccination Record Card;
(iii) A copy of medical records documenting the vaccination;
(iv) A copy of immunization records from a public health, state, or tribal
immunization information system; or
(v) A copy of any other official documentation that contains the type of vaccine
administered, date(s) of administration, and the name of the health care
professional(s) or clinic site(s) administering the vaccine(s);
(vi) In instances where an employee is unable to produce acceptable proof of
vaccination under paragraphs (e)(2)(i) through (v) of this section, a signed and
dated statement by the employee:
(A) Attesting to their vaccination status (fully vaccinated or partially
vaccinated);
(B) Attesting that they have lost and are otherwise unable to produce proof
required by this section; and
(C) Including the following language: “I declare (or certify, verify, or state)
that this statement about my vaccination status is true and accurate. I
understand that knowingly providing false information regarding my
vaccination status on this form may subject me to criminal penalties.”
Note 1 to paragraph (e)(2)(vi): An employee who attests to their vaccination
status should, to the best of their recollection, include the following information in
their attestation: the type of vaccine administered; date(s) of administration; and
the name of the health care professional(s) or clinic site(s) administering the
vaccine(s).
(3) Any employee who does not provide one of the acceptable forms of proof of
vaccination status in paragraph (e)(2) of this section to the employer must be
treated as not fully vaccinated for the purpose of this section.
(4) The employer must maintain a record of each employee’s vaccination status and
must preserve acceptable proof of vaccination for each employee who is fully or
partially vaccinated. The employer must maintain a roster of each employee’s
vaccination status. These records and roster are considered to be employee
medical records and must be maintained as such records in accordance with
§1910.1020 and must not be disclosed except as required or authorized by this
section or other federal law. These records and roster are not subject to the
retention requirements of § 1910.1020(d)(1)(i) but must be maintained and
preserved while this section remains in effect.
(5) When an employer has ascertained employee vaccination status prior to the
effective date of this section through another form of attestation or proof, and
retained records of that ascertainment, the employer is exempt from the
requirements in paragraphs (e)(1) through (3) of this section only for each
employee whose fully vaccinated status has been documented prior to the
effective date of this section. For purposes of paragraph (e)(4) of this section, the
employer’s records of ascertainment of vaccination status for each such person
constitute acceptable proof of vaccination.
(f) Employer support for employee vaccination. The employer must support COVID-19
vaccination as described in this paragraph.
(1) Time for vaccination. The employer must:
(i) Provide a reasonable amount of time to each employee for each of their
primary vaccination dose(s); and
(ii) Provide up to 4 hours paid time, including travel time, at the employee’s
regular rate of pay for this purpose.
(2) Time for recovery. The employer must provide reasonable time and paid sick
leave to recover from side effects experienced following any primary vaccination
dose to each employee for each dose.
(g) COVID-19 testing for employees who are not fully vaccinated.
(1) The employer must ensure that each employee who is not fully vaccinated complies with paragraph
(g)(1)(i) or (ii) of this section:
(i) An employee who reports at least once every 7 days to a workplace where
other individuals such as coworkers or customers are present:
(A)Must be tested for COVID-19 at least once every 7 days; and
(B) Must provide documentation of the most recent COVID-19 test result to
the employer no later than the 7th day following the date on which the
employee last provided a test result.
(ii) An employee who does not report during a period of 7 or more days to a
workplace where other individuals such as coworkers or customers are present
(e.g., teleworking for two weeks prior to reporting to a workplace with
others):
(A)Must be tested for COVID-19 within 7 days prior to returning to the
workplace; and
(B) Must provide documentation of that test result to the employer upon return
to the workplace.
Note 1 to paragraph (g)(1): This section does not require the employer to pay for any
costs associated with testing; however employer payment for testing may be required
by other laws, regulations, or collective bargaining agreements or other collectively
negotiated agreements. This section also does not prohibit the employer from paying
for costs associated with testing required by paragraph (g)(1) of this section.
(2) If an employee does not provide documentation of a COVID-19 test result as
required by paragraph (g)(1) of this section, the employer must keep that
employee removed from the workplace until the employee provides a test result.
(3) When an employee has received a positive COVID-19 test, or has been diagnosed
with COVID-19 by a licensed healthcare provider, the employer must not require
that employee to undergo COVID-19 testing as required under paragraph (g) of
this section for 90 days following the date of their positive test or diagnosis.
(4) The employer must maintain a record of each test result provided by each
employee under paragraph (g)(1) of this section or obtained during tests
conducted by the employer. These records are considered to be employee
medical records and must be maintained as such records in accordance with §
1910.1020 and must not be disclosed except as required or authorized by this
section or other federal law. These records are not subject to the retention
requirements of § 1910.1020(d)(1)(i) but must be maintained and preserved while
this section remains in effect.
(h) Employee notification to employer of a positive COVID-19 test and removal.
Regardless of COVID-19 vaccination status or any COVID-19 testing required under
paragraph (g) of this section, the employer must:
(1) Require each employee to promptly notify the employer when they receive a
positive COVID-19 test or are diagnosed with COVID-19 by a licensed
healthcare provider; and
(2) Immediately remove from the workplace any employee who receives a positive
COVID-19 test or is diagnosed with COVID-19 by a licensed healthcare provider
and keep the employee removed until the employee:
(i) Receives a negative result on a COVID-19 nucleic acid amplification test
(NAAT) following a positive result on a COVID-19 antigen test if the
employee chooses to seek a NAAT test for confirmatory testing;
(ii) meets the return to work criteria in CDC’s “Isolation Guidance” (incorporated
by reference, § 1910.509); or
(iii) Receives a recommendation to return to work from a licensed healthcare
provider.
Note 1 to paragraph (h)(2): This section does not require employers to provide paid
time to any employee for removal as a result of a positive COVID-19 test or
diagnosis of COVID-19; however, paid time may be required by other laws,
regulations, or collective bargaining agreements or other collectively negotiated
agreements.
(i) Face coverings.
(1) The employer must ensure that each employee who is not fully
vaccinated wears a face covering when indoors and when occupying a vehicle with
another person for work purposes, except:
(i) When an employee is alone in a room with floor to ceiling walls and a closed
door.
(ii) For a limited time while the employee is eating or drinking at the workplace
or for identification purposes in compliance with safety and security
requirements.
(iii) When an employee is wearing a respirator or facemask.
(iv) Where the employer can show that the use of face coverings is infeasible or
creates a greater hazard that would excuse compliance with this paragraph
(e.g., when it is important to see the employee’s mouth for reasons related to
their job duties, when the work requires the use of the employee’s uncovered
mouth, or when the use of a face covering presents a risk of serious injury or
death to the employee).
(2) The employer must ensure that any face covering required to be worn by this
section:
(i) Is worn by the employee to fully cover the employee’s nose and mouth; and
(ii) Is replaced when wet, soiled, or damaged (e.g., is ripped, has holes, or has
broken ear loops).
(3) The employer must not prevent any employee from voluntarily wearing a face
covering or facemask unless the employer can demonstrate that doing so would
create a hazard of serious injury or death, such as interfering with the safe
operation of equipment.
(4) The employer must permit the employee to wear a respirator instead of a face
covering whether required or not. In addition, the employer may provide
respirators to the employee, even if not required. In such circumstances, the
employer must also comply with § 1910.504.
(5) The employer must not prohibit customers or visitors from wearing face
coverings.
Note 1 to paragraph (i)(5): Nothing in this section precludes employers from
requiring customers or visitors to wear face coverings.
Note 1 to paragraph (i): Face shields may be worn in addition to face coverings to
prevent them from getting wet and soiled.
Note 2 to paragraph (i): This section does not require the employer to pay for any costs
associated with face coverings; however employer payment for face coverings may be
required by other laws, regulations, or collective bargaining agreements or other
collectively negotiated agreements. This section also does not prohibit the employer
from paying for costs associated with face coverings required by this section.
(j) Information provided to employees. The employer must inform each employee, in a
language and at a literacy level the employee understands, about:
(1) The requirements of this section as well as any employer policies and procedures
established to implement this section;
(2) COVID-19 vaccine efficacy, safety, and the benefits of being vaccinated, by
providing the document, “Key Things to Know About COVID-19 Vaccines,”
available at https://www.cdc.gov/coronavirus/2019-
ncov/vaccines/keythingstoknow.html;
(3) The requirements of 29 CFR 1904.35(b)(1)(iv), which prohibits the employer
from discharging or in any manner discriminating against an employee for
reporting a work-related injuries or illness, and section 11(c) of the OSH Act,
which prohibits the employer from discriminating against an employee for
exercising rights under, or as a result of actions that are required by, this section.
Section 11(c) also protects the employee from retaliation for filing an
occupational safety or health complaint, reporting a work-related injuries or
illness, or otherwise exercising any rights afforded by the OSH Act; and
(4) The prohibitions of 18 U.S.C. 1001 and of section 17(g) of the OSH Act, which
provide for criminal penalties associated with knowingly supplying false
statements or documentation.
(k) Reporting COVID-19 fatalities and hospitalizations to OSHA.
(1) The employer must
report to OSHA:
(i) Each work-related COVID-19 fatality within 8 hours of the employer learning
about the fatality.
(ii) Each work-related COVID-19 in-patient hospitalization within 24 hours of the
employer learning about the in-patient hospitalization.
(2) When reporting COVID-19 fatalities and in-patient hospitalizations to OSHA in
accordance with paragraph (j)(1) of this section, the employer must follow the
requirements in 29 CFR part 1904.39, except for 29 CFR part 1904.39(a)(1) and
(2) and (b)(6).
(l) Availability of records.
(1) By the end of the next business day after a request, the
employer must make available, for examination and copying, the individual COVID-19
vaccine documentation and any COVID-19 test results for a particular employee to that
employee and to anyone having written authorized consent of that employee.
(2) By the end of the next business day after a request by an employee or an
employee representative, the employer must make available to the requester the
aggregate number of fully vaccinated employees at a workplace along with the
total number of employees at that workplace.
(3) The employer must provide to the Assistant Secretary for examination and
copying:
(i) Within 4 business hours of a request, the employer’s written policy required by
paragraph (d) of this section, and the aggregate numbers described in
paragraph (l)(2) of this section; and
(ii) By the end of the next business day after a request, all other records and other
documents required to be maintained by this section.
(m) Dates—
(1) Effective date. This section is effective as of [INSERT DATE OF
PUBLICATION IN THE FEDERAL REGISTER].
(2) Compliance dates.
(i) Employers must comply with all requirements of this
section, except for requirements in paragraph (g) of this section, by [INSERT
DATE 30 DAYS AFTER DATE OF PUBLICATION IN THE FEDERAL
REGISTER].
(ii) Employers must comply with the requirements of this section in paragraph (g)
by [INSERT DATE 60 DAYS AFTER DATE OF PUBLICATION IN THE
FEDERAL REGISTER], but employees who have completed the entire
primary vaccination by that date do not have to be tested, even if they have
not yet completed the 2-week waiting period.
4. Amend § 1910.504 by revising paragraph (a) to read as follows:
§ 1910.504 Mini Respiratory Protection Program.
(a) Scope and application. This section applies only to respirator use in accordance with
§§ 1910.501(i)(4) and 1910.502(f)(4).
* * * * *
5. Republish § 1910.505 to read as follows:
§ 1910.505 Severability.
Each section of this subpart U, and each provision within those sections, is separate and
severable from the other sections and provisions. If any provision of this subpart is held
to be invalid or unenforceable on its face, or as applied to any person, entity, or
circumstance, or is stayed or enjoined, that provision shall be construed so as to continue
to give the maximum effect to the provision permitted by law, unless such holding shall
be one of utter invalidity or unenforceability, in which event the provision shall be
severable from this subpart and shall not affect the remainder of the subpart.
6. Amend § 1910.509 by revising paragraph (b)(5) to read as follows:
§ 1910.509 Incorporation by reference.
* * * * *
(b) * * *
(5) Isolation Guidance. COVID-19: Isolation If You Are Sick; Separate yourself from
others if you have COVID-19, updated February 18, 2021, IBR approved for §§
1910.501(h) and 1910.502(l).
* * * * *
PART 1915—OCCUPATIONAL SAFETY AND HEALTH STANDARDS FOR
SHIPYARD EMPLOYMENT
7. The authority citation for part 1915 is revised to read as follows:
Authority: 33 U.S.C. 941; 29 U.S.C. 653, 655, 657; Secretary of Labor’s Order
No. 12-71 (36 FR 8754); 8-76 (41 FR 25059), 9-83 (48 FR 35736), 1-90 (55 FR 9033), 6-
96 (62 FR 111), 3-2000 (65 FR 50017), 5-2002 (67 FR 65008), 5-2007 (72 FR 31160), 4-
2010 (75 FR 55355), 1-2012 (77 FR 3912), or 8-2020 (85 FR 58393); 29 CFR part 1911;
and 5 U.S.C. 553, as applicable.
Subpart Z – Toxic and Hazardous Substances
8. Add § 1915.1501 to subpart Z to read as follows:
§ 1915.1501 COVID-19.
The requirements applicable to shipyard employment under this section are identical to
those set forth at 29 CFR 1910.501.
PART 1917—MARINE TERMINALS
9. The authority citation for part 1917 is revised to read as follows:
Authority: 33 U.S.C. 941; 29 U.S.C. 653, 655, 657; Secretary of Labor’s Order
No. 12-71 (36 FR 8754), 8-76 (41 FR 25059), 9-83 (48 FR 35736), 1-90 (55 FR 9033), 6-
96 (62 FR 111), 3-2000 (65 FR 50017), 5-2002 (67 FR 65008), 5-2007 (72 FR 31160), 4-
2010 (75 FR 55355), 1-2012 (77 FR 3912), or 8-2020 (85 FR 58393), as applicable; and
29 CFR part 1911.
Sections 1917.28 and 1917.31 also issued under 5 U.S.C. 553.
Section 1917.29 also issued under 49 U.S.C. 1801-1819 and 5 U.S.C. 553.
Subpart B – Marine Terminal Operations
10. Add § 1917.31 to subpart B to read as follows:
§ 1917.31 COVID-19.
The requirements applicable to marine terminal work under this section are identical to
those set forth at 29 CFR 1910.501.
PART 1918—SAFETY AND HEALTH REGULATIONS FOR LONGSHORING
11. The authority citation for part 1918 is revised to read as follows:
Authority: 33 U.S.C. 941; 29 U.S.C. 653, 655, 657; Secretary of Labor’s Order
No. 12-71 (36 FR 8754), 8-76 (41 FR 25059), 9-83 (48 FR 35736), 1-90 (55 FR 9033), 6-
96 (62 FR 111), 3-2000 (65 FR 50017), 5-2002 (67 FR 65008), 5-2007 (72 FR 31160), 4-
2010 (75 FR 55355), 1-2012 (77 FR 3912), or 8-2020 (85 FR 58393), as applicable; and
29 CFR 1911.
Sections 1918.90 and 1918.110 also issued under 5 U.S.C. 553.
Section 1918.100 also issued under 49 U.S.C. 5101 et seq. and 5 U.S.C. 553.
12. Add subpart K to part 1918 to read as follows:
Subpart K – COVID-19.
Sec.
1918.107 — 1918.109 [Reserved]
1918.110 COVID-19.
1918.107 through 1918.109 [Reserved]
§ 1918.110 COVID-19.
The requirements applicable to longshoring work under this section are identical to those
set forth at 29 CFR 1910.501.
PART 1926—SAFETY AND HEALTH REGULATIONS FOR CONSTRUCTION
13. The authority citation for part 1926 is revised to read as follows:
Authority: 40 U.S.C. 3704; 29 U.S.C. 653, 655, and 657; and Secretary of
Labor’s Order No. 12-71 (36 FR 8754), 8-76 (41 FR 25059), 9-83 (48 FR 35736), 1-90
(55 FR 9033), 6-96 (62 FR 111), 3-2000 (65 FR 50017), 5-2002 (67 FR 65008), 5-2007
(72 FR 31159), 4-2010 (75 FR 55355), 1-2012 (77 FR 3912), or 8-2020 (85 FR 58393),
as applicable; and 29 CFR part 1911.
Sections 1926.58, 1926.59, 1926.60, and 1926.65 also issued under 5 U.S.C. 553
and 29 CFR part 1911.
Section 1926.61 also issued under 49 U.S.C. 1801-1819 and 5 U.S.C. 553.
Section 1926.62 also issued under sec. 1031, Public Law 102-550, 106 Stat. 3672
(42 U.S.C. 4853).
Section 1926.65 also issued under sec. 126, Public Law 99-499, 100 Stat. 1614
(reprinted at 29 U.S.C.A. 655 Note) and 5 U.S.C. 553.
Subpart D – Occupational Health and Environmental Controls
14. Add § 1926.58 to read as follows:
§ 1926.58 COVID-19.
The requirements applicable to construction work under this section are identical to those
set forth at 29 CFR 1910.501 Subpart U.
PART 1928—OCCUPATIONAL SAFETY AND HEALTH STANDARDS FOR
AGRICULTURE
15. The authority citation for part 1928 is revised to read as follows:
Authority: Sections 4, 6, and 8 of the Occupational Safety and Health Act of
1970 (29 U.S.C. 653, 655, 657); Secretary of Labor’s Order No. 12-71 (36 FR 8754), 8-
76 (41 FR 25059), 9-83 (48 FR 35736), 1-90 (55 FR 9033), 6-96 (62 FR 111), 3-2000 (65
FR 50017), 5-2002 (67 FR 65008), 4-2010 (75 FR 55355), or 8-2020 (85 FR 58393), as
applicable; and 29 CFR 1911.
Section 1928.21 also issued under 49 U.S.C. 1801-1819 and 5 U.S.C. 553.
Subpart B – Applicability of Standards
16. Amend § 1928.21 by adding paragraph (a)(8) to read as follows:
§ 1928.21 Applicable standards in 29 CFR part 1910.
(a) * * *
(8) COVID-19- §1910.501, but only with respect to –
(i) Agricultural establishments where eleven (11) or more employees are engaged
on any given day in hand-labor operations in the field; and
(ii) Agricultural establishments that maintain a temporary labor camp, regardless
of how many employees are engaged on any given day in hand-labor
operations in the field.
* * * * *
[FR Doc. 2021-23643 Filed: 11/4/2021 8:45 am; Publication Date: 11/5/2021
MORE ACTION ALERTS
Help Oppose Massachusetts SB 905 and SB 907
November 22, 2017
WI: Act Now to Protect Consumer Access to Natural Health Practitioners!
November 17, 2017